EUVIMEDEUVIMED entdecken
Crossref

Outcomes after Modified Pediatric Emergency Care Applied Research Network Procalcitonin Rule Implementation in Febrile Infant Care Process Model

Jared Olson iD, Frank Cipriano, Amani Jridi, Roni D Lane, Per H Gesteland, Adam L Hersh, Carolyn Reynolds, Marilyn Valentine, R Neil Davis, Jeff Schunk, Emily A Thorell

Journal of the Pediatric Infectious Diseases Society · 2026

DOI: 10.1093/jpids/piag087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2026. Verfasst von Jared Olson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah, Salt Lake City, UT, United S…. Hauptthemen laut MEDLINE: Procalcitonin, Fever, Clinical Decision Rules, Bacterial Infections. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stratification of well-appearing febrile infants into a low-risk category for invasive bacterial infections (IBI) is critical to optimizing patient care. Procalcitonin (PCT), a biomarker associated with bacterial infection, was included in the 2019 Pediatric Emergency Care Applied Research Network (PECARN) clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infection. That same year, we incorporated a modified PECARN febrile infant prediction rule into our existing febrile infant algorithm. The primary objective of the study was to evaluate the effect of the modified PECARN prediction rule on rate of lumbar puncture (LP), hospital admissions, and 30-day readmissions.

Methods

We identified febrile infants 3 to 90 days evaluated in our emergency department from November 2017 through April 2022. The pre-implementation period was from November 2017 to June 2019. The modified PECARN rule was incorporated into the clinical care process model between July 2019 and August 2019. The post-implementation period was September 2019 through April 2022. The primary outcomes were LP rate and hospital admissions. The primary process metric was PCT obtainment. The balancing metric was 30-day readmissions. Between group comparisons were performed with Chi square tests.

Results

A total of 1520 febrile infants were included in the analysis, 662 in the pre-implementation period, and 858 in the post-implementation period. Lumbar puncture rate and hospital admissions decreased from 45.8% to 31.0% (P < .001) and from 54.1% to 43.2% (P < .001), respectively. The percentage of infants with a PCT increased from 3.9% to 94.1% post-implementation (P < .001). The 30-day readmission rate was 3.5% in the pre-implementation and 4.8% in the post-implementation period (P = .26).

Conclusion

Incorporation of the modified PECARN prediction rule to an existing febrile infant care process model resulted in decreased lumbar punctures and hospital admissions without significantly increasing 30-day readmissions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProcalcitoninFeverClinical Decision RulesBacterial InfectionsHumansInfantSpinal PunctureMaleFemaleInfant, NewbornPatient ReadmissionEmergency Service, HospitalBiomarkersHospitalization

Stichwörter der Autor:innen

antimicrobial stewardshipfebrile infantguideline implementationprocalcitoninquality improvement

Substanzen

ProcalcitoninBiomarkers

Autor:innen und Institutionen

  • Division of Pediatric Infectious Diseases, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah, Salt Lake City, UT, United States.
  • Department of Pharmacy, Primary Children's Hospital, Salt Lake City, UT, United States.
  • Division of Pediatric Hospitalist Medicine, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah, Salt Lake City, UT, United States.
  • Department of Population Health Sciences, The University of Utah, Salt Lake City, UT, United States.
  • Division of Pediatric Emergency Medicine, Department of Pediatrics, Spencer Fox School of Medicine, University of Utah, Salt Lake City, UT, United States.
  • Intermountain Health, Intermountain Children's Health, Murray, UT, United States.

ORCID-Profile: Jared Olson

Zitieren

APA

Olson, J., Cipriano, F., Jridi, A., Lane, R. D., Gesteland, P. H., Hersh, A. L., Reynolds, C., Valentine, M., Davis, R. N., Schunk, J., & Thorell, E. A. (2026). Outcomes after Modified Pediatric Emergency Care Applied Research Network Procalcitonin Rule Implementation in Febrile Infant Care Process Model. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piag087

Vancouver

Olson J, Cipriano F, Jridi A, Lane RD, Gesteland PH, Hersh AL, et al. Outcomes after Modified Pediatric Emergency Care Applied Research Network Procalcitonin Rule Implementation in Febrile Infant Care Process Model. Journal of the Pediatric Infectious Diseases Society. 2026. doi:10.1093/jpids/piag087

BibTeX
@article{Olson2026,
  author = {Olson, Jared and Cipriano, Frank and Jridi, Amani and Lane, Roni D and Gesteland, Per H and Hersh, Adam L and Reynolds, Carolyn and Valentine, Marilyn and Davis, R Neil and Schunk, Jeff and Thorell, Emily A},
  title = {Outcomes after Modified Pediatric Emergency Care Applied Research Network Procalcitonin Rule Implementation in Febrile Infant Care Process Model},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2026},
  doi = {10.1093/jpids/piag087}
}
Kostenlos starten →